Historical record - last NADAC effective date: 2/21/2018
Product Information
RELION NOVOLIN 70-30 VIAL is a brand product labeled by Novo Nordisk, priced at $13.4759 per ML under NDC 00169183702. Its NADAC has been published 262 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Novo NordiskNDC
00169183702
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
2/21/2018
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA019991On Market Since
6/25/1991
Pharmacological Classes
Price Statistics
The NADAC for RELION NOVOLIN 70-30 VIAL has been published 262 times since Nov 28, 2013, and over the history we have for it it has risen 67.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.4759 per ML |
|---|---|
| All-time high | $13.4759 (Nov 28, 2018) |
| All-time low | $8.0708 (Nov 28, 2013) |
| Median price | $12.4714 |
| Average price | $12.0548 |
| Largest weekly change | +9.9% (Nov 26, 2014) |
| Weeks tracked | 262 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+67.0%
Last surveyed Nov 28, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Human Insulin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RELION NOVOLIN 70-30 VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RELION NOVOLIN 70-30 VIAL, manufactured by Novo Nordisk, is $13.4759 per ML (NDC 00169183702), effective Nov 28, 2018.
How has the price of RELION NOVOLIN 70-30 VIAL changed over time?
Over the history we have for it, the NADAC for RELION NOVOLIN 70-30 VIAL has risen 67.0%. It has been tracked across 262 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RELION NOVOLIN 70-30 VIAL?
Since Nov 28, 2013, the NADAC for RELION NOVOLIN 70-30 VIAL has ranged from a low of $8.0708 (Nov 28, 2013) to a high of $13.4759 (Nov 28, 2018), with a median of $12.4714 per ML.
Are there cheaper alternatives to RELION NOVOLIN 70-30 VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NOVOLIN N 100 UNIT/ML VIAL, is $4.6226 per ML — about 66% below RELION NOVOLIN 70-30 VIAL.
Who manufactures RELION NOVOLIN 70-30 VIAL?
RELION NOVOLIN 70-30 VIAL (NDC 00169183702) is labeled by Novo Nordisk, and CMS classifies it as a brand product.